Author:
Agarwal Tushar,Manandhar Suman,B Harish Kumar,Famurewa Ademola C.,Gurram Prasada Chowdari,Suggala Ramya Shri,Sankhe Runali,Mudgal Jayesh,Pai K. Sreedhara Ranganath
Abstract
AbstractAlzheimer’s disease (AD) is associated with cognitive deficits and epigenetic deacetylation that can be modulated by natural products. The role of natural oxyresveratrol-β-cyclodextrin (ORV) on cognition and histone deacetylase activity in AD is unclear. Herein, in-silico docking and molecular dynamics simulation analysis determined that oxyresveratrol potentially targets histone deacetylase-2 (HDAC2). We therefore evaluated the in vivo ameliorative effect of ORV against cognitive deficit, cerebral and hippocampal expression of HDAC in experimental AD rats. Intracerebroventricular injection of STZ (3 mg/kg) induced experimental AD and the rats were treated with low dose (200 mg/kg), high dose (400 mg/kg) of ORV and donepezil (10 mg/kg) for 21 days. The STZ-induced AD caused cognitive and behavioural deficits demonstrated by considerable increases in acetylcholinesterase activity and escape latency compared to sham control. The levels of malondialdehyde (MDA) and HDAC activity were significantly increased in AD disease group comparison to the sham. Interestingly, the ORV reversed the cognitive-behavioural deficit and prominently reduced the MDA and HDAC levels comparable to the effect of the standard drug, donepezil. The findings suggest anti-AD role of ORV via antioxidant effect and inhibition of HDAC in the hippocampal and frontal cortical area of rats for AD.
Funder
MAHE IMF grant
Manipal Academy of Higher Education, Manipal
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Elmorsy, E., Elsharkawy, E., Alhumaydhi, F. A. & Salama, M. The protective effect of Indian Catechu methanolic extract against aluminum chloride-induced neurotoxicity, A rodent model of Alzheimer’s disease. Heliyon 7, e06269 (2021).
2. Falode, J. A., Akinmoladun, A. C., Olaleye, M. T. & Akindahunsi, A. A. Sausage tree (Kigelia africana) flavonoid extract is neuroprotective in AlCl3-induced experimental Alzheimer’s disease. Pathophysiology 24, 251–259 (2017).
3. Park, J. et al. Streptozotocin induces Alzheimer’s disease-like pathology in hippocampal neuronal cells via CDK5/Drp1-mediated mitochondrial fragmentation. Front. Cell. Neurosci. 14, 1–11 (2020).
4. Pang, Q. Q. et al. Cirsium japonicum var. Maackii improves cognitive impairment under amyloid Beta25–35-induced Alzheimer’s disease model. Biomed. Res. Int. 2022, 1–11 (2022).
5. Janczura, K. J. et al. Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proc. Natl. Acad. Sci. USA 115, E11148–E11157 (2018).